Project Details
Description
A Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg in Patients with Post-Operative Pain
| Status | Finished |
|---|---|
| Effective start/end date | 3/15/16 → 3/14/19 |
Funding
- ACELRX PHARMACEUTICALS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.